Related Experiment Videos
Verification of the interaction between peptide T and CD4 using surface plasmon resonance
T E Ramsdale1, P R Andrews, E C Nice
1Centre for Drug Design and Development, University of Queensland, St. Lucia, Australia.
FEBS Letters
|November 1, 1993
Summary
Peptide T binds to CD4, the cellular receptor for HIV's gp120 protein. This interaction, confirmed by biosensor technology, supports its potential role in treating AIDS-associated dementia.
Area of Science:
- Immunology
- Virology
- Neuroscience
Background:
- Peptide T is investigated for AIDS-associated dementia treatment.
- Its proposed mechanism involves inhibiting HIV gp120 binding to the CD4 receptor.
- Previous studies yielded conflicting results regarding Peptide T's inhibitory effect.
Purpose of the Study:
- To investigate the direct interaction between Peptide T and the CD4 receptor.
- To validate the hypothesis that Peptide T binds to CD4.
Main Methods:
- Utilized a novel biosensor technique to detect molecular interactions.
- Analyzed the binding kinetics of Peptide T with CD4.
- Employed an anti-CD4 monoclonal antibody to confirm binding specificity.
Main Results:
- Demonstrated direct binding of Peptide T to the CD4 receptor.
- Confirmed that this binding is specific and can be inhibited by an anti-CD4 antibody.
- Provided a detailed kinetic analysis of the Peptide T-CD4 interaction.
Conclusions:
- Peptide T directly interacts with the CD4 receptor.
- The findings support the hypothesis that Peptide T's mechanism of action involves CD4 binding.
- This study validates a novel biosensor approach for studying such interactions.